학술논문
Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma
Document Type
Article
Author
Source
In: PLoS ONE . (PLoS ONE, April 2024, 19(4 April))
Subject
Language
English
ISSN
19326203